Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Nephrology

Building Your Care Team and Staying Ahead of the Disease

At a Glance

People with kidney tubulopathy-dilated cardiomyopathy syndrome need coordinated kidney, heart, genetics, and emotional support. Because no standard monitoring schedule exists, specialists should tailor testing, medication follow-up, emergency instructions, and coping support.

Because Kidney tubulopathy-dilated cardiomyopathy syndrome (ADKH-RRAGD) is an ultra-rare condition—(with roughly 37 to 50 individuals described in 2024 and 2025 reports)—you can be an informed partner supported by a coordinated care team [1]. Managing this syndrome requires a group of specialists who are willing to work together and stay updated on the rapidly evolving research [2].

Building Your Specialist Team

A “one-doctor” approach is rarely enough for this condition. You should aim to build a team that includes:

  • Nephrologist (Kidney Specialist): Someone familiar with “salt-wasting” tubulopathies. They will manage your magnesium and potassium levels and monitor for calcium buildup in the kidneys [1].
  • Heart Failure or Transplant Cardiologist: Even if your heart function is currently normal, having a cardiologist who specializes in complex heart muscle diseases is essential [3]. They have the most experience with the medications and imaging needed for this syndrome.
  • Clinical Geneticist: This specialist can help you understand your specific variant and provide guidance for screening family members [4].
  • Medical Psychologist or Counselor: Managing a lifelong, ultra-rare diagnosis is a heavy burden. A professional can help you navigate the unique stress of frequent monitoring [5].

Your Monitoring Schedule

Because there is no “official” protocol for such a rare disease, there is no standard monitoring schedule. Your specialists will determine the exact timing based on your symptoms, medication changes, ventricular function, and lab stability [2][6]. For instance, medication changes may require lab checks within days, while stable periods allow for longer intervals [1][7].

Consider requesting a written shared care summary and an individualized care-plan template with your emergency instructions, target lab plan, and medication list [6][8].

Navigating “Scanxiety” and the Burden of Care

The term scanxiety describes the intense anxiety that many patients feel before and after medical imaging [5]. For an ultra-rare condition, this stress is often amplified by the wait for results and the rarity of the disease itself.

To help manage the psychological toll:

  • Request Fast Results: Research shows that every additional day spent waiting for results increases the odds of significant anxiety [5]. Ask your care team if results can be released to your portal immediately or if a brief call can be scheduled.
  • Standardize Your Prep: Using distraction (like music or podcasts) or relaxation techniques during the scan itself can lower pre-scan stress [9][10].
  • Find Your Community: While ADKH-RRAGD is very rare, there are online forums and peer support groups for “rare disease” patients and for “inherited cardiomyopathies” [11]. These groups can provide the validation that comes from talking to others who understand the “waiting game” of chronic monitoring [12].
  • Coping Styles: If you tend to “ruminate” or worry about the future, focusing on present-moment coping or self-guided stress management programs may help reduce daily distress [13][14].

Common questions in this guide

Which specialists should be part of an ADKH-RRAGD care team?
A care team commonly includes a kidney specialist, a heart-failure or transplant cardiologist, a clinical geneticist, and a psychologist or counselor. Because ADKH-RRAGD is very rare, coordinated communication among these specialists is important.
How often should I have echocardiograms and electrolyte tests?
There is no official monitoring schedule for ADKH-RRAGD. Testing may be needed within days after a medication change, while stable periods may allow longer intervals; your specialists should set the timing based on symptoms, heart function, and lab stability.
How can I coordinate care between my kidney and heart specialists?
Ask your team to identify one clinician who oversees the big picture and to create a written shared-care summary. It can include your target lab plan, medication list, emergency instructions, and a process for sharing results between specialists.
What is scanxiety, and how can I manage it?
Scanxiety is intense anxiety before or after medical imaging. Asking about faster access to results, using music or relaxation techniques during the scan, and connecting with rare-disease or inherited-cardiomyopathy support groups may help.
When should I call my doctor or seek emergency care?
Ask your specialists to write down the specific laboratory levels, symptoms, or other changes that should prompt a call or emergency evaluation. The right thresholds depend on your medications, kidney function, heart function, and overall care plan, so do not rely on a general online cutoff.

Get notified when new evidence is published on Kidney tubulopathy-dilated cardiomyopathy syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Novel RRAGD Variants in Autosomal Dominant Kidney Hypomagnesemia and Therapeutic Perspectives.

    Adella A, Jouret F, Madariaga L, et al.

    Kidney international reports 2025; (10(10)):3640-3655 doi:10.1016/j.ekir.2025.07.035.

    PMID: 41141537
  2. 2

    RRAGD-Associated Autosomal Dominant Kidney Hypomagnesemia with Cardiomyopathy: A Review on the Clinical Manifestations and Therapeutic Options.

    Trepiccione F, Sambri I, Ruggiero B, et al.

    Kidney & blood pressure research 2024; (49(1)):637-645 doi:10.1159/000539889.

    PMID: 38901414
  3. 3

    mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy.

    Schlingmann KP, Jouret F, Shen K, et al.

    Journal of the American Society of Nephrology : JASN 2021; (32(11)):2885-2899 doi:10.1681/ASN.2021030333.

    PMID: 34607910
  4. 4

    Genetic Counseling in Kidney Disease: A Perspective.

    Stein Q, Westemeyer M, Darwish T, et al.

    Kidney medicine 2023; (5(7)):100668 doi:10.1016/j.xkme.2023.100668.

    PMID: 37334143
  5. 5

    Scanxiety and quality of life around follow-up imaging in patients with unruptured intracranial aneurysms: a prospective cohort study.

    Kamphuis MJ, van der Kamp LT, van Eijk RPA, et al.

    European radiology 2024; (34(9)):6018-6025 doi:10.1007/s00330-024-10602-0.

    PMID: 38311702
  6. 6

    Clinical care of family members of patients with dilated cardiomyopathy.

    Verdonschot JAJ, Kaski JP, Asselbergs FW, et al.

    European heart journal 2025; (46(43)):4569-4582 doi:10.1093/eurheartj/ehaf571.

    PMID: 40902100
  7. 7

    The challenges of diagnosis and management of Gitelman syndrome.

    Urwin S, Willows J, Sayer JA

    Clinical endocrinology 2020; (92(1)):3-10 doi:10.1111/cen.14104.

    PMID: 31578736
  8. 8

    The contribution of cardiopulmonary exercise testing in the familial screening for dilated and non-dilated left ventricular cardiomyopathies: case series.

    Del Mestre E, Capovilla TM, Paldino A, et al.

    European heart journal. Case reports 2025; (9(4)):ytaf162 doi:10.1093/ehjcr/ytaf162.

    PMID: 40302978
  9. 9

    Effect of information delivery techniques in reducing pre-procedural anxiety in computed tomography.

    Ahmed HS, Gupta D, Aluru DR, et al.

    Current problems in diagnostic radiology 2024; (53(6)):723-727 doi:10.1067/j.cpradiol.2024.07.015.

    PMID: 39019712
  10. 10

    Audiovisual intervention alleviates anxiety of patients during PET/CT imaging.

    Abouzian S, Camacho V, Sabaté A, et al.

    Nuklearmedizin. Nuclear medicine 2022; (61(4)):301-307 doi:10.1055/a-1759-4062.

    PMID: 35931063
  11. 11

    "We are a club none of us wanted to join": exploring brain tumor online discussion forum content.

    Muasher-Kerwin C, Hughes MC, Foster ML, Econie SM

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025; (33(6)):510 doi:10.1007/s00520-025-09545-z.

    PMID: 40437290
  12. 12

    Relational Aspects to Screening-Associated Distress Among Individuals With Li-Fraumeni Syndrome: "The All-Clear for Me Is Good. The All-Clear for My Kids Is Great".

    Huelsnitz CO, Werner-Lin A, Forbes Shepherd R, et al.

    Qualitative health research 2025; 10497323251365787 doi:10.1177/10497323251365787.

    PMID: 40947678
  13. 13

    Coping With 'Scanxiety': Within-Person Processes in Lung Cancer.

    Dunsmore VJ, Neupert SD

    Psychological reports 2025; (128(2)):702-722 doi:10.1177/00332941231164336.

    PMID: 36964680
  14. 14

    Stress Management Program for Scanxiety in People With Advanced Lung Cancer: Intervention Adaptation and Stakeholder Feedback.

    Derry-Vick H, Khoudary A, Billini O, et al.

    Psycho-oncology 2025; (34(1)):e70048 doi:10.1002/pon.70048.

    PMID: 39804222

This page is for informational purposes only and does not constitute medical advice about ADKH-RRAGD. Your nephrologist, cardiologist, and other specialists should set your monitoring schedule and emergency plan.

Guide contents Kidney tubulopathy-dilated cardiomyopathy syndrome
Research & Literature
05 Treatment and Management